KRTAP5-7
gene geneOn this page
Also known as KRTAP5.7KRTAP5-3
Summary
KRTAP5-7 (keratin associated protein 5-7, HGNC:23602) is a protein-coding gene on chromosome 11q13.4, encoding Keratin-associated protein 5-7 (Q6L8G8). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….
Predicted to be located in cytosol.
Source: NCBI Gene 440050 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 69 total
- MANE Select transcript:
NM_001012503
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23602 |
| Approved symbol | KRTAP5-7 |
| Name | keratin associated protein 5-7 |
| Location | 11q13.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRTAP5.7, KRTAP5-3 |
| Ensembl gene | ENSG00000244411 |
| Ensembl biotype | protein_coding |
| Entrez | 440050 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000398536
RefSeq mRNA: 1 — MANE Select: NM_001012503
NM_001012503
CCDS: CCDS41682
Canonical transcript exons
ENST00000398536 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001533519 | 71527267 | 71528669 |
Expression profiles
Bgee: expression breadth broad, 50 present calls, max score 57.67.
Top tissues by expression
85 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| substantia nigra | UBERON:0002038 | 57.67 | gold quality |
| hypothalamus | UBERON:0001898 | 55.55 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 55.44 | gold quality |
| putamen | UBERON:0001874 | 55.21 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 55.20 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 54.89 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 54.60 | gold quality |
| nucleus accumbens | UBERON:0001882 | 54.46 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 54.31 | gold quality |
| right frontal lobe | UBERON:0002810 | 54.24 | gold quality |
| caudate nucleus | UBERON:0001873 | 54.14 | gold quality |
| Ammon’s horn | UBERON:0001954 | 53.81 | gold quality |
| cerebral cortex | UBERON:0000956 | 52.87 | gold quality |
| left testis | UBERON:0004533 | 52.85 | gold quality |
| temporal lobe | UBERON:0001871 | 52.77 | gold quality |
| amygdala | UBERON:0001876 | 52.67 | gold quality |
| right testis | UBERON:0004534 | 52.59 | gold quality |
| testis | UBERON:0000473 | 52.38 | gold quality |
| frontal cortex | UBERON:0001870 | 51.40 | gold quality |
| brain | UBERON:0000955 | 51.14 | gold quality |
| primary visual cortex | UBERON:0002436 | 50.67 | gold quality |
| cortical plate | UBERON:0005343 | 49.79 | gold quality |
| prefrontal cortex | UBERON:0000451 | 49.52 | gold quality |
| cerebellar cortex | UBERON:0002129 | 48.81 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 48.78 | gold quality |
| cerebellum | UBERON:0002037 | 48.74 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 48.53 | gold quality |
| ventricular zone | UBERON:0003053 | 47.85 | silver quality |
| right lobe of liver | UBERON:0001114 | 47.19 | gold quality |
| bone marrow cell | CL:0002092 | 45.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting KRTAP5-7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-4519 | 99.48 | 66.10 | 859 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-6165 | 99.44 | 67.12 | 1389 |
| HSA-MIR-1286 | 99.09 | 66.23 | 1046 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
| HSA-MIR-4731-3P | 98.56 | 68.60 | 1860 |
| HSA-MIR-4266 | 98.53 | 67.29 | 1035 |
| HSA-MIR-769-5P | 94.45 | 64.56 | 603 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 5-7 — Q6L8G8 (reviewed: Q6L8G8)
Alternative names: Keratin-associated protein 5-3, Keratin-associated protein 5.3, Keratin-associated protein 5.7, Ultrahigh sulfur keratin-associated protein 5.7
All UniProt accessions (1): Q6L8G8
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Expressed in hair root but not in skin.
Similarity. Belongs to the KRTAP type 5 family.
RefSeq proteins (1): NP_001012521* (*=MANE)
Domains & families (InterPro)
UniProt features (9 total): repeat 7, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6L8G8-F1 | 41.99 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 16 (showing top):
chr11q13, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR4283, MIR4779, GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP, GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN, GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN, GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP, GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
280 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP5-7 | KRTAP5-11 | Q6L8G4 | 715 |
| KRTAP5-7 | KRTAP5-5 | Q701N2 | 665 |
| KRTAP5-7 | OR2G3 | Q8NGZ4 | 608 |
| KRTAP5-7 | KRTAP5-10 | Q6L8G5 | 582 |
| KRTAP5-7 | KRTAP19-8 | Q3LI54 | 580 |
| KRTAP5-7 | OR1N1 | Q8NGS0 | 575 |
| KRTAP5-7 | NPIPB13 | A6NJU9 | 574 |
| KRTAP5-7 | OR2G2 | Q8NGZ5 | 573 |
| KRTAP5-7 | OR14A16 | Q8NHC5 | 540 |
| KRTAP5-7 | KRTAP16-1 | A8MUX0 | 527 |
| KRTAP5-7 | OR56A3 | Q8NH54 | 515 |
| KRTAP5-7 | OR8B12 | Q8NGG6 | 507 |
| KRTAP5-7 | OR5M10 | Q6IEU7 | 507 |
| KRTAP5-7 | OR11L1 | Q8NGX0 | 480 |
| KRTAP5-7 | KRTAP5-6 | Q6L8G9 | 479 |
IntAct
186 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP5-7 | KRTAP4-2 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP5-7 | KRTAP5-6 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP4-2 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE2D | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | MACO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHLDA1 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | LCE3D | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | ZNF440 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3E | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | MRGBP | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | UXT | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | ZNF613 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | SHFL | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE4A | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | GUCD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| WNT11 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATA3 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | PTPMT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3A | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SCARF1 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HHEX | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAPKBP1 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | SAMD11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IL2RG | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-7 | IGSF8 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (70): KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid), KRTAP5-7 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: Q6L8G4, Q6L8G8
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 60 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 18 | 22.8× | 2e-18 |
| Formation of the cornified envelope | 11 | 22.0× | 1e-10 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 11 | 49.5× | 5e-14 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
69 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
439 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:71527493:G:GT | donor_gain | 0.9900 |
| 11:71527494:G:T | donor_gain | 0.9900 |
| 11:71527468:C:G | donor_gain | 0.9500 |
| 11:71527786:GT:G | donor_gain | 0.9500 |
| 11:71527494:G:GT | donor_gain | 0.9000 |
| 11:71527944:A:T | donor_gain | 0.9000 |
| 11:71527994:A:G | acceptor_gain | 0.8800 |
| 11:71527981:A:G | acceptor_gain | 0.8600 |
| 11:71528058:G:C | acceptor_gain | 0.8400 |
| 11:71527497:G:GT | donor_gain | 0.8300 |
| 11:71527980:A:AG | acceptor_gain | 0.8300 |
| 11:71527429:GCCC:G | donor_gain | 0.8200 |
| 11:71527814:TCTC:T | donor_gain | 0.8200 |
| 11:71527820:G:GG | donor_gain | 0.8200 |
| 11:71528443:CCTA:C | acceptor_loss | 0.8200 |
| 11:71528444:CTAG:C | acceptor_loss | 0.8200 |
| 11:71528445:TA:T | acceptor_loss | 0.8200 |
| 11:71528446:A:AC | acceptor_loss | 0.8200 |
| 11:71528447:G:A | acceptor_loss | 0.8200 |
| 11:71527326:G:GT | donor_gain | 0.8100 |
| 11:71527524:G:T | donor_gain | 0.8100 |
| 11:71527467:GCT:G | donor_gain | 0.8000 |
| 11:71527792:G:GT | donor_gain | 0.8000 |
| 11:71528327:C:CA | acceptor_gain | 0.8000 |
| 11:71527993:A:AG | acceptor_gain | 0.7900 |
| 11:71527995:G:GG | acceptor_gain | 0.7700 |
| 11:71528430:GAAC:G | acceptor_gain | 0.7700 |
| 11:71528430:GAACC:G | acceptor_gain | 0.7500 |
| 11:71527389:G:T | donor_gain | 0.7200 |
| 11:71527472:G:GA | donor_gain | 0.7200 |
AlphaMissense
1065 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:71527794:T:G | I165S | 0.675 |
| 11:71527794:T:C | I165T | 0.647 |
| 11:71527673:A:C | S125R | 0.607 |
| 11:71527675:C:A | S125R | 0.607 |
| 11:71527675:C:G | S125R | 0.607 |
| 11:71527792:G:C | K164N | 0.595 |
| 11:71527792:G:T | K164N | 0.595 |
| 11:71527429:G:C | K43N | 0.591 |
| 11:71527429:G:T | K43N | 0.591 |
| 11:71527794:T:A | I165N | 0.565 |
dbSNP variants (sampled 300 via entrez): RS1000287674 (11:71526487 C>A,G), RS1000840404 (11:71527777 G>A), RS1001457926 (11:71525516 C>A,T), RS1002612003 (11:71527874 C>A,T), RS1002708454 (11:71528176 C>T), RS1003599478 (11:71529076 A>C), RS1004402730 (11:71526791 C>T), RS1006629255 (11:71528845 G>A), RS1006971759 (11:71528641 C>A), RS1008183703 (11:71527190 T>C), RS1010869115 (11:71526679 A>ACCATGAGGAAAAGCT), RS1011497896 (11:71528903 A>G,T), RS1012755665 (11:71527508 T>C), RS1014318420 (11:71525571 C>T), RS1014539823 (11:71526543 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Estradiol | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.